FLNA · NASDAQ
Filana Therapeutics (FLNA) Stock Price & Fundamentals
Filana Therapeutics (FLNA) closed at $360.33 on Oct 9, 2026, up 1.30% from the previous close of $355.72.
Share price, past year
1Y −8.03%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $360.33 |
| Sep 30, 2026 | $362.51 |
| Aug 31, 2026 | $364.01 |
| Jul 31, 2026 | $361.00 |
| Jun 30, 2026 | $362.53 |
| May 29, 2026 | $369.03 |
| Apr 30, 2026 | $375.55 |
| Mar 31, 2026 | $388.86 |
| Feb 27, 2026 | $389.60 |
| Jan 30, 2026 | $380.96 |
| Dec 31, 2025 | $369.63 |
| Nov 28, 2025 | $382.14 |
| Oct 31, 2025 | $365.61 |
Key statistics
- Market cap
- $17.41B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.88
- Revenue (TTM)
- —
- Net income (TTM)
- −$77.90M
- Shares outstanding
- 48.3M
- Dividend yield
- —
- 52-week range
- $347.64 – $396.77
Filana Therapeutics's market cap is $17.41B, based on a share price of $360.33 and 48.3M shares outstanding as of Mar 31, 2026.
Financials
Filana Therapeutics reported revenue of $41.12M for fiscal 2013, up 277.58% from fiscal 2012.
Filana Therapeutics reported a net loss of $90.97M in fiscal 2025.
Fiscal 2013 revenue was the highest in the 5 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2013ended Dec 31, 2013 | $41.12M | +277.6% | — | — | — | — |
| FY2012ended Dec 31, 2012 | $10.89M | −5.2% | — | — | — | — |
| FY2011ended Dec 31, 2011 | $11.48M | −31.7% | — | — | — | — |
| FY2010ended Dec 31, 2010 | $16.81M | −18.3% | — | — | — | — |
| FY2009ended Dec 31, 2009 | $20.56M | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2013ended Dec 31, 2013 | $35.24M | — | — |
| Q3 FY2013ended Sep 30, 2013 | $1.96M | — | — |
| Q2 FY2013ended Jun 30, 2013 | $1.96M | — | — |
| Q1 FY2013ended Mar 31, 2013 | $1.96M | — | — |
| Q4 FY2012ended Dec 31, 2012 | $2.47M | — | — |
| Q3 FY2012ended Sep 30, 2012 | $2.73M | — | — |
| Q2 FY2012ended Jun 30, 2012 | $2.72M | — | — |
| Q1 FY2012ended Mar 31, 2012 | $2.97M | — | — |
Company profile
- Name
- Filana Therapeutics, Inc.
- Ticker
- FLNA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 6801 N Capital Of Texas Highway, Building 1; Suite 300, Austin, TX 78731
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001069530
Recent SEC filings
- Sep 22, 2026
- Sep 18, 2026
- Jul 29, 2026
- Jul 29, 2026
- Jun 15, 2026
- May 7, 2026
- May 7, 2026
- Apr 28, 2026
Frequently asked questions
What is Filana Therapeutics's stock price?
Filana Therapeutics (FLNA) closed at $360.33 on Oct 9, 2026, up 1.30% from the previous close of $355.72.
What is Filana Therapeutics's market cap?
Filana Therapeutics's market cap is $17.41B, based on a share price of $360.33 and 48.3M shares outstanding as of Mar 31, 2026.
How much revenue does Filana Therapeutics make?
Filana Therapeutics reported revenue of $41.12M for fiscal 2013, up 277.58% from fiscal 2012.
Does Filana Therapeutics pay a dividend?
Filana Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Filana Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures